Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases. [electronic resource]

By:

Al-Kawaaz, Mustafa

Contributor(s):

Mathew, Susan
Liu, Yifang
Gomez, Maria L
Chaviano, Felicia
Knowles, Daniel M
Orazi, Attilio
Tam, Wayne

Producer: 20150311Description: 288-99 p. digitalISSN:

1943-7722

Subject(s):

Biomarkers, Tumor -- genetics
Cyclin D1 -- metabolism
DNA-Binding Proteins -- genetics
Gene Rearrangement
Humans
Immunohistochemistry
In Situ Hybridization, Fluorescence
Lymphoma, Large B-Cell, Diffuse -- genetics
Male
Middle Aged
Oncogene Proteins, Fusion -- genetics
Polymerase Chain Reaction
Proto-Oncogene Proteins c-bcl-6
Tissue Array Analysis
Translocation, Genetic

Online resources:

Available from publisher's website

In: American journal of clinical pathology vol. 143

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

Browse results Close

Back to results

21 Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy.
by Henry, N L
22 Plasma letrozole concentrations in postmenopausal women with breast cancer are associated with CYP2A6 genetic variants, body mass index, and age.
by Desta, Z
23 Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients.
by Rae, J M
24 Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer.
by Hertz, D L
25 A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer.
by Rothenberg, M L
26 Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
by Burris, H A
27 Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.
by Henry, D H
28 Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects.
by Henry, N L

Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases.

APA

Al-Kawaaz M., Mathew S., Liu Y., Gomez M. L., Chaviano F., Knowles D. M., Orazi A. & Tam W. (20150311). Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases. : American journal of clinical pathology.

Chicago

Al-Kawaaz Mustafa, Mathew Susan, Liu Yifang, Gomez Maria L, Chaviano Felicia, Knowles Daniel M, Orazi Attilio and Tam Wayne. 20150311. Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases. : American journal of clinical pathology.

Harvard

Al-Kawaaz M., Mathew S., Liu Y., Gomez M. L., Chaviano F., Knowles D. M., Orazi A. and Tam W. (20150311). Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases. : American journal of clinical pathology.

MLA

Al-Kawaaz Mustafa, Mathew Susan, Liu Yifang, Gomez Maria L, Chaviano Felicia, Knowles Daniel M, Orazi Attilio and Tam Wayne. Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases. : American journal of clinical pathology. 20150311.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC